Establishment of Autochthonous & Standard Cell Line Derived Xenograft Models of Glioblastoma Multiform in Iran
Abstract
Background: GBM is the most common and malignant astrocity tumor and it is persistent to common treatment so, these patients have a very low survival.Several researchers around the world, including Iran, have been investigated GBM-cell line in vitro. However in vivo studies have not been fulfilled.Methods: As standard cell line (U-87MG) derived from human GBM and total GBM tumor derived from 3 patients were heterotypic ally injected into 4-6 weeks old athymic nude mice. Pathologic investigation by H&E, GFAP and Ki-67 were examined 2 months post implantation.Results: GBM characteristics appeared in H&E and GFAP and the rate of proliferation was 6% and in direct xenograft tumor was 9% which was consistent with the pathologic result of patient.Conclusion: GBM Xengraft is the most suitable model for in vivo investigation and researcher can evaluate new treatments for this tumor. On the other hands, Pharmacogenomics differences in treatment response could be indicated among Iranians.Lopes MBS, B. H. Central Nervous System Tumors. In: Weidner N, Cote RJ, Suster S, eds WL, editors. Modern surgical pathology. 1 ed. Philadelphia: W.B. Saunders 2003. p. 2063-9.
Kumar V, Fausto N, Abbas A, Aster J. The central Nervous system. In: Matthew P. Frosch, Douglas C. Anthony, Girolami UD, editors. Robbins and Cotran Pathologic Basis of Disease. New York: W.B. Saunders 2010. p. 1464.
Charles B Stevenson, Thompson RC. Neurosurgical oncology: neoplasms of the brain and meninges. In: Poston GJ, editor. Textbook of Surgical oncology. Distributed in North and South America: Taylor & Francis; 2007. p. 393-410.
DeVita VT, Hellman S, Rosenberg SA. Principles & Practice of Oncology. 8 ed. T DV, S H, Rosenberg SA, editors. Philadelphia: Lippincott Williams & Wilkins; 2008.
Dickinson PJ, LeCouteur RA, Higgins RJ, Bringas JR, Larson RF, Yamashita Y, et al. Canine spontaneous glioma: a translational model system for convection-enhanced delivery. Neuro Oncol. 2010 Sep;12(9):928-40.
Lipsitz D, Higgins RJ, Kortz GD, Dickinson PJ, Bollen AW, Naydan DK, et al. Glioblastoma multiforme: clinical findings, magnetic resonance imaging, and pathology in five dogs. Vet Pathol. 2003 Nov;40(6):659-69.
Conn PM. Canine and Feline Models for Cancer. In: Vico De Gionata MP, editor. Source Book of Models for Biomedical Research2008. p. 794
Pantelouris EM. Absence of thymus in a mouse mutant. Nature. 1968 Jan 27;217(5126):370-1.
Rygaard J, Povlsen CO. Heterotransplantation of a human malignant tumour to "Nude" mice. Acta Pathol Microbiol Scand. 1969;77(4):758-60.
Sarkaria JN, Carlson BL, Schroeder MA, Grogan P, Brown PD, Giannini C, et al. Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2264-71.
Zhao Y, Xiao A, diPierro CG, Carpenter JE, Abdel-Fattah R, Redpath GT, et al. An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9. Am J Pathol. 2010 Jun;176(6):3032-49.
Kerbel RS. Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceivedbut they can be improved. Cancer Biol Ther. 2003 Jul- Aug;2(4 Suppl 1):S134-9.
Aldape. K CH, James. C.D. Models of malignant glioma Drug Discovery Today: Disease Models. 2006;3(2):191-6.
Vredenburgh JJ, Desjardins A, Herndon JE, 2nd, Marcello J, Reardon DA, Quinn JA, et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol. 2007 Oct 20;25(30):4722-9.
Files | ||
Issue | Vol 3 No 1 (2011) | |
Section | Original Articles | |
Keywords | ||
Glioblastom Xengraft Tumor |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |